Keywords: Forest Labs, Fourth-quarter and full-year 2011/12 financial results

Forest Labs profit plunges as Lexapro loses patent

Article | 18 April 2012

Print This

US drugmaker Forest Laboratories (NYSE: FRX) that reported earnings per share equaled $0.72 in the fourth quarter of fiscal 2012, down a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in